RESPONSE OF CENTRAL PAIN SYNDROMES TO INTRAVENOUS LIDOCAINE

被引:33
作者
BACKONJA, M
GOMBAR, KA
机构
[1] Pain Clinic, University of Wisconsin Hospital and Clinics, Madison, Wisconsin
[2] Department of Neurology, University of Wisconsin Hospital and Clinics, Madison, Wisconsin
[3] W.S. Middleton Veterans Administration Hospital, Madison, Wisconsin
关键词
CENTRAL NEUROPATHIC PAIN; LIDOCAINE; PLACEBO; MECHANISMS;
D O I
10.1016/S0885-3924(06)80010-2
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
In this study, 8 patients with central pain syndromes, 6 with hemispheric lesions, and 2 with spinal cord lesions were treated with a 1 mg/kg dose of intravenous lidocaine. Patients first received the same volume of normal saline, in single-blind fashion, to monitor placebo effects. Of the 8 patients, 7 responded to lidocaine, and only 1 responded to normal saline. Responses ranged from partial to complete. All components of central pain, including constant pain, paroxysms of pain, and evoked pain, responded to lidocaine. In addition, 3 patients had pain relief that lasted for 8-20 wk. These findings, which are in agreement with two previous open-label studies, suggest that a single dose of a local anesthetic, lidocaine, can provide lasting pain relief for patients with central pain syndromes. This analgesic action may be central, and possibly supraspinal, at least in patients with hemispheric lesions.
引用
收藏
页码:172 / 178
页数:7
相关论文
共 18 条
  • [1] Beric A, Dimitrijevic MR, Lindblum U, Central dysesthesia syndrome in spinal cord injury patients, Pain, 34, pp. 109-116, (1988)
  • [2] Boivie J, Leijon G, Johansson I, Central post-stroke pain—a study of the mechanisms through analysis of the sensory abnormalities, Pain, 37, pp. 173-185, (1989)
  • [3] Tasker RR, Dostrovsky JO, Deafferentation and central pain, Textbook of pain, pp. 154-180, (1989)
  • [4] Boas RA, Covinio BG, Shahnarian A, Analgesic responses to iv lignocaine, Br J Anaesth, 54, pp. 501-505, (1982)
  • [5] Edwards WT, Habib F, Burney RG, Begin G, Intravenous lidocaine in the management of various chronic pain states: a review of 211 cases, Reg Anaesth, 10, pp. 1-10, (1985)
  • [6] Graubard DJ, Robertazzi RW, Peterson MC, One year experience with intravenous procaine, Anesth Analg, 27, pp. 222-226, (1948)
  • [7] Macicwicz R, Chung RY, Strassman A, Hochberg F, Moskowitz M, Relief of vascular headache with intravenous lidocaine: clinical observations and a proposed mechanism, The Clinical Journal of Pain, 4, pp. 11-16, (1988)
  • [8] Kastrup J, Petersen P, Dejgard A, Angelo HR, Hilsted J, Intravenous lidocaine infusion—a new treatment of chronic painful diabetic neuropathy?, Pain, 28, pp. 69-75, (1987)
  • [9] Schnapp M, Mays KS, North WC, Intravenous 2-choloroprocine in treatment of chronic pain, Anesth Analg, 60, pp. 844-845, (1981)
  • [10] Loh L, Nathan PW, Schott GD, Pain due to lesions of central nervous system removed by sympathetic block, Br Med J [Clin Res], 282, pp. 1026-1028, (1981)